PMID: 11921108Mar 29, 2002Paper

Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey

Movement Disorders : Official Journal of the Movement Disorder Society
Luis Erik ClaveríaJesús de Pedro-Cuesta

Abstract

We assessed the prevalence of Parkinson's disease in Cantalejo, Spain. In 1994, we screened 1,579 persons (age > or = 40 years) using a high-sensitivity method. Cases fulfilling established clinical criteria were followed for a minimum of 3 years. Prevalences were compared with those from other door-to-door surveys. We detected 27 individuals with parkinsonism, 20 of whom had Parkinson's disease. The prevalence of Parkinson's disease increased with age and, when age-adjusted to European standards, was 9.01 per 1,000 (age 40 years and over; 10.78 in men and 5.23 in women). Of the 11 men, three were in Hoehn & Yahr grades III-IV, but six of the nine women were more severely affected. Overall, we found 18 newly diagnosed cases of parkinsonism, 13 of which were Parkinson's disease, and the majority of which were in men aged 80 years or older with a mean duration of illness of 5 years. Our prevalence figures are the highest reported, apparently because of the inclusion of several very elderly men. Parkinson's disease in Cantalejo is less severe in men than in women, particularly in those newly diagnosed. Despite the low numbers, the high prevalence and sex-related pattern are unexplained but they probably relate to the high sensitiv...Continue Reading

References

Jan 1, 1989·Neuroepidemiology·M Cruz Gutierrez-del-OlmoA Portera-Sanchez
Dec 1, 1988·Archives of Neurology·N E BharuchaB S Schoenberg
Aug 1, 1994·Acta Neurologica Scandinavica·F TisonP Henry
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·J DuarteD B Calne
Mar 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·M O MelconW A Rocca
May 1, 1997·Neurology·M C de RijkD M Maraganore
Jun 23, 1998·Journal of Clinical Epidemiology·W A RoccaD J Schaid
Aug 1, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·D W AndersonD M Maraganore
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Maria Dolores SevillanoLuis Erik Clavería

❮ Previous
Next ❯

Citations

Nov 14, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·Charlotte A HaaxmaMartin W I M Horstink
Oct 6, 2009·Journal of Epidemiology·Weerasak MuangpaisanCarol Brayne
Dec 22, 2009·Neurological Research·Jong-Min KimBeom S Jeon
Feb 22, 2014·Semergen·J A Martínez-PérezE Dragomir
Oct 6, 2012·Journal of Medical Economics·Francesc ValldeoriolaUNKNOWN Workgroup of the SCOPE study
Sep 4, 2015·PloS One·Jesús de Pedro-CuestaMiguel Calero
Jul 3, 2013·Neurología : publicación oficial de la Sociedad Española de Neurología·R García-RamosP Mir
Oct 21, 2016·Molecular Neurobiology·Anelya Kh AlievaMaria I Shadrina
Nov 26, 2015·The Annals of Otology, Rhinology, and Laryngology·Julia K EllerstonKatherine A Kendall
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Maria Dolores SevillanoLuis Erik Clavería
Oct 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Amir GlikRivka Inzelberg
Nov 30, 2018·Health Informatics Journal·Riyi QiuLixia Yao
Aug 29, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Francesc ValldeoriolaPablo Martínez-Martín
May 10, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P LindgrenR Dodel
Oct 4, 2005·Pharmacoepidemiology and Drug Safety·G LaraS Luis-González
Jul 28, 2013·European Journal of Epidemiology·Katerina MensikovaVladimír Janout
Jul 8, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Christine KleinAnthony E Lang
Jun 3, 2011·European Journal of Epidemiology·Karin WirdefeldtJack Mandel
Jul 1, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Tamara PringsheimThomas D L Steeves
Oct 12, 2016·Acta Neurologica Scandinavica·M NeriusG Doblhammer
Mar 3, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J J FerreiraA B Lima
Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Julián Benito-LeónUNKNOWN Neurological Disorders in Central Spain (NEDICES) Study Group
Jul 20, 2010·Acta Neurologica Scandinavica·J Virués-OrtegaUNKNOWN Spanish Epidemiological Studies on Ageing Group
Oct 28, 2018·Journal of the American Medical Directors Association·Sung Bae ParkJayeun Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
J Benito-LeónNeurological Disorders in Central Spain (NEDICES) Study Group
Movement Disorders : Official Journal of the Movement Disorder Society
J M ErreaJesús de Pedro-Cuesta
Movement Disorders : Official Journal of the Movement Disorder Society
M O MelconW A Rocca
© 2022 Meta ULC. All rights reserved